LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

11.4 1.15

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.14

Max

11.6

Chiffres clés

By Trading Economics

Revenu

479M

-5.4M

Ventes

-14M

402M

Marge bénéficiaire

-1.344

Employés

4,396

EBITDA

526M

54M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+14.84% upside

Dividendes

By Dow Jones

Prochains Résultats

26 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-404M

852M

Ouverture précédente

10.25

Clôture précédente

11.4

Sentiment de l'Actualité

By Acuity

78%

22%

329 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 févr. 2026, 23:44 UTC

Actions en Tendance

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 févr. 2026, 23:20 UTC

Résultats

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 févr. 2026, 22:57 UTC

Résultats

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 févr. 2026, 21:59 UTC

Résultats

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 févr. 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 févr. 2026, 23:54 UTC

Market Talk

Global Equities Roundup: Market Talk

17 févr. 2026, 23:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 févr. 2026, 23:45 UTC

Market Talk

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 févr. 2026, 23:19 UTC

Résultats

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 23:15 UTC

Résultats

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 22:58 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 févr. 2026, 22:58 UTC

Acquisitions, Fusions, Rachats

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 févr. 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 févr. 2026, 22:50 UTC

Acquisitions, Fusions, Rachats

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 févr. 2026, 22:44 UTC

Résultats

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 22:42 UTC

Résultats

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 févr. 2026, 22:36 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 févr. 2026, 22:36 UTC

Résultats

Santos Final Dividend 10.3 U.S. Cents/Security

17 févr. 2026, 22:36 UTC

Résultats

Santos FY Underlying Profit US$898 Million, Down 25%

17 févr. 2026, 22:35 UTC

Résultats

Santos FY Revenue US$4.94 Billion, Down 8%

17 févr. 2026, 22:35 UTC

Résultats

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 févr. 2026, 22:35 UTC

Acquisitions, Fusions, Rachats

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 févr. 2026, 22:34 UTC

Résultats

Santos FY Net Profit US$818 Billion, Down 33%

17 févr. 2026, 22:02 UTC

Acquisitions, Fusions, Rachats

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 févr. 2026, 21:50 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 févr. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

17 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 févr. 2026, 21:49 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 févr. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 févr. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

14.84% hausse

Prévisions sur 12 Mois

Moyen 13 USD  14.84%

Haut 13 USD

Bas 13 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

329 / 351Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat